glp-1 receptor antagonist agonists show promise in treating substance use disorders GLP-1 Receptor Agonists | New

GLP-1 receptor agonist medications are synthetic versions of this hormone that work by mimicking what your body already does, just more effectively

Hank Capps, chief information and digital officer of Wellstar Health System and president of Catalyst by Wellstar, joined a discussion moderated by Stephen Konya, a senior advisor to the deputy national coordinator for health IT and innovation portfolio lead at the U.S

Many believe these supplements can be good additions to standard treatments

Who Should Stay on Lisdexamfetamine Despite Cheaper Options Generic lisdexamfetamine is now cost-competitive enough that the "cost vs